Intermediate Anti-coagulation May Benefit All Hospitalized Patients with COVID-19
This article shows that all hospitalized patients may benefit from at least an intermediate anti-coagulation treatment.
Link to the article.
Link to the pdf version.
doi: Link
To quote this article in bibliography:
Poulakou, Garyphallia, Evangelos Dimakakos, Anastasios Kollias, et al. “Beneficial Effects of Intermediate Dosage of Anticoagulation Treatment on the Prognosis of Hospitalized COVID-19 Patients: The ETHRA Study." In Vivo 35, no. 1 (2021): 653-661. https://doi.org/10.21873/invivo.12305
Join us in the social media!
Click here to subscribe to our Telegram Channel!
Click here to join to our Telegram Group for discussions
Monitor Image downloaded form iStock. A Standard License was purchased which allows the use of the file for any personal, business or commercial purposes that aren't otherwise restricted by the license.
0
0
0.000
Congratulations @secondmedicalop! You have completed the following achievement on the Hive blockchain and have been rewarded with new badge(s) :
You can view your badges on your board and compare yourself to others in the Ranking
If you no longer want to receive notifications, reply to this comment with the word
STOP